FATE - Fate Therapeutics Inc. (FATE) CEO Scott Wolchko on Q4 2020 Results - Earnings Call Transcript

Fate Therapeutics, Inc. (FATE) Q4 2020 Earnings Conference Call February 24, 2021 17:00 ET Corporate Participants Scott Wolchko - President and Chief Executive Officer Ed Dulac - Chief Financial Officer Bob Valamehr - Chief Development Officer Wayne Chu - Senior Vice President, Clinical Development Conference Call Participants Srikripa Devarakonda - Truist Securities Alethia Young - Cantor Michael Schmidt - Guggenheim Yigal Nochomovitz - Citi Mara Goldstein - Mizuho Matt Biegler - Oppenheimer Carolina Ibanez Ventoso - Stifel Biren Amin - Jefferies Peter Lawson - Barclays Nick Abbott - Wells Fargo Presentation Operator Welcome to the Fate Therapeutics Fourth Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section on Fate's Web site at fatetherapeutics.com. As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, President and

For further details see:

Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q4 2020 Results - Earnings Call Transcript